From: Correlation between B7-H3 expression and matrix metalloproteinases 2 expression in pancreatic cancer
Pathologic parameter | Cases(N) | MMP2 expression positive rate % | χ2 | P value |
---|---|---|---|---|
Male | 27 | 63.0 (17/27) | 0.065 | 0.799 |
Female | 18 | 66.7 (12/18) | ||
Age < 60 | 19 | 73.7 (14/19) | 1.225 | 0.268 |
Age ≥60 | 26 | 57.7 (15/26) | ||
Located in head | 37 | 67.6 (25/37) | 0.886 | 0.642 |
Located in tail | 6 | 50 (3/6) | ||
Whole pancreas cancer | 2 | 50 (1/2) | ||
Size of primary carcinoma(<3 cm) | 30 | 73.3 (22/30) | 3.103 | 0.978 |
Size of primary carcinoma(≥3 cm) | 15 | 46.7 (7/15) | ||
Histodifferentiation(II) | 26 | 84.6 (22/26) | 11.109 | 0.004* |
Histodifferentiation(III) | 7 | 43.9 (3/7) | ||
Histodifferentiation(IV) | 12 | 33.3 (4/12) | ||
Lymph nodes metastasis Negative | 20 | 35 (7/20) | 13.621 | 0.000* |
Lymph nodes metastasis Positive | 25 | 88 (22/25) | ||
pTNM stage I | 9 | 22.2 (2/9) | 23.377 | 0.000* |
pTNM stage II | 11 | 45.5 (5/11) | ||
pTNM stage III | 12 | 75 (9/12) | ||
pTNM stage IV | 13 | 100 (13/13) | ||
Normal tissue | 27 | 0 (0/27) |